Basic information Safety Related Supplier
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Inhibitors >  Proteases >  DPP-4 inhibitors >  ALOGLIPTIN(ALOGLIPTINE, ALOGLIPTINA)

ALOGLIPTIN(ALOGLIPTINE, ALOGLIPTINA)

Basic information Safety Related Supplier
ALOGLIPTIN(ALOGLIPTINE, ALOGLIPTINA) Basic information
ALOGLIPTIN(ALOGLIPTINE, ALOGLIPTINA) Chemical Properties
  • Boiling point:519.2±60.0 °C(Predicted)
  • Density 1.342
  • Flash point:267.8℃
  • pka9.89±0.20(Predicted)
Safety Information
ALOGLIPTIN(ALOGLIPTINE, ALOGLIPTINA) Usage And Synthesis
  • DescriptionAlogliptin is a dipeptidyl-peptidase IV (DPP-4) inhibitor that was approved in Japan in 2010 for treatment of type 2 diabetes, a disease in which insulin resistance and β-cell dysfunction lead to hyperglycemia. As islet function is lost, the severity of insulin resistance increases. The introduction of DPP-4 inhibitors has brought a novel class of insulinotropic agents for the treatment options available to type 2 diabetic patients. The therapeutic potential of glucagon-like peptide 1 (GLP-1), an incretin peptide, for the treatment of type 2 diabetes was realized in the 1990s. The insulinotropic effects of GLP-1 depend closely on glucose concentrations providing the possibility of glucose normalization without the risk of hypoglycemia. GLP-1 has other non-insulinotropic physiological actions that are advantageous. It suppresses glucagon secretion from a cells and slows gastric emptying, which contributes to satiety and to a slower passage and reabsorption of carbohydrates. GLP-1 also contributes to satiety via a central mechanism as a neurotransmitter with effects on the hypothalamus.
  • Chemical PropertiesWhite Solid
  • OriginatorSyrrx Inc. (now Takeda San Diego) (Japan)
  • UsesAlogliptin is an oral antihyperglycemic agent that is a selective inhibitor of the enzyme dipeptidyl peptidase-4 (DPP-4). Antidiabetic agent.
  • DefinitionChEBI: A piperidine that is 3-methyl-2,4-dioxo-3,4-dihydropyrimidine carrying additional 2-cyanobenzyl and 3-aminopiperidin-1-yl groups at positions 1 and 2 respectively (the R-enantiomer). Used in the form of its benzoate salt for treatment of t pe 2 diabetes.
  • brand nameNesina
ALOGLIPTIN(ALOGLIPTINE, ALOGLIPTINA)(850649-61-5)Related Product Information
ALOGLIPTIN(ALOGLIPTINE, ALOGLIPTINA)SupplierMore
  • Company Name:Hefei Topway Biotechnology Co.,Ltd Gold
  • Tel:14755135869 0551-65326752
  • Email:sales@ahtopway.com
  •  
  • Company Name:J & K SCIENTIFIC LTD.
  • Tel:400-666-7788 010-82848833-
  • Email:jkinfo@jkchemical.com;market6@jkchemical.com
  •  
  • Company Name:Chemvon Biotechnology Co., Ltd
  • Tel:021-50790412-
  • Email:info@chemvon.com
  •  
  • Company Name:Chemsky(shanghai)International Co.,Ltd.
  • Tel:021-50135380
  • Email:shchemsky@sina.com
  •  
  • Company Name:XiaoGan ShenYuan ChemPharm co,ltd
  • Tel:15527768850 0712-2580635-
  • Email:1791901229@qq.com;1791901229@qq.com;
  •